SEM Financials Select Medical Holdings Corp

15 years of revenue, profit, cash flow and balance-sheet history through FY2025, from SEC filings — with a computed, factual read of the trend. Updated 28 h ago Overview →

Growth & profitability

Revenue has declined 0.3% per year over the past 5 years.
Net income has grown slower than revenue (-10.8% vs -0.3% per year).
Operating margin has contracted, at 6.2% in the latest year.
Free cash flow has declined 33.2% per year over the past 5 years.

Financial health

Total debt has grown faster than revenue (17.3% vs -0.3% per year).
Operating income covered interest expense 2.9× in the latest year.

Shareholder returns

Dividends have been paid for 5 consecutive years, consuming 21.5% of earnings and 26.8% of free cash flow.

Revenue & net income

RevenueNet income

Margins (gross / operating / net)

GrossOperatingNet

Free cash flow (CFO − capex)

Free cash flow

Cash vs total debt

CashTotal debt

Cash flow: operating / investing / financing

OperatingInvestingFinancing

Key annual figures

FY	Revenue	Net income	Gross M	Op M	FCF	Total debt	Cash
2025	$5.5B	$146M	0.0%	6.2%	$117M	—	$27M
2024	$5.2B	$214M	0.0%	5.2%	$296M	—	$60M
2023	$4.8B	$243M	0.0%	5.5%	$353M	—	$53M
2022	$4.6B	$159M	0.0%	3.1%	$94M	—	$98M
2021	$6.2B	$402M	0.0%	11.5%	$221M	—	$74M
2020	$5.5B	$259M	0.0%	10.3%	$882M	—	$577M
2019	$5.5B	$148M	0.0%	8.7%	$288M	$3.4B	$336M
2018	$5.1B	$138M	0.0%	8.2%	$327M	$3.3B	$175M
2017	$4.4B	$177M	0.0%	8.2%	$5M	$2.7B	$123M
2016	$4.2B	$115M	0.0%	7.1%	$185M	$2.7B	$99M
2015	—	$131M	—	—	$26M	—	$14M
2014	—	$121M	—	—	—	$1.6B	$3M
2013	—	$114M	—	—	—	$1.4B	$4M
2012	—	$148M	—	—	—	$1.5B	$40M
2011	—	$108M	—	—	$171M	$1.4B	$12M

Revenue & net income

RevenueNet income

Margins (gross / operating / net)

GrossOperatingNet

Free cash flow (CFO − capex, quarterly)

Free cash flow

Cash vs total debt

CashTotal debt

Cash flow: operating / investing / financing

OperatingInvestingFinancing

Key quarterly figures

Quarter	Revenue	Net income	Gross M	Op M	FCF	Total debt	Cash
Mar '26	$1.4B	$44M	0.0%	6.9%	-$21M	—	$26M
Dec '25	$1.4B	$20M	0.0%	4.6%	$5M	—	$27M
Sep '25	$1.4B	$29M	0.0%	5.4%	$122M	—	$60M
Jun '25	$1.3B	$41M	0.0%	6.5%	$46M	—	$52M
Mar '25	$1.4B	$57M	0.0%	8.3%	-$56M	—	$53M
Dec '24	$1.3B	-$16M	0.0%	1.6%	$62M	—	$60M
Sep '24	$1.3B	$56M	0.0%	4.3%	$130M	—	$191M
Jun '24	$1.3B	$78M	0.0%	5.8%	$223M	—	$111M
Mar '24	$1.3B	$97M	0.0%	9.0%	-$119M	—	$93M
Dec '23	$1.2B	$46M	0.0%	-14.2%	$119M	—	$53M
Sep '23	$1.2B	$48M	0.0%	10.9%	$66M	—	$77M
Jun '23	$1.2B	$78M	0.0%	13.2%	$175M	—	$101M
Mar '23	$1.7B	$71M	0.0%	9.1%	-$7M	—	$84M
Dec '22	$1.6B	$28M	0.0%	5.5%	-$43M	—	$98M
Sep '22	$1.6B	$27M	0.0%	5.8%	$52M	—	$108M
Jun '22	$1.6B	$55M	0.0%	7.6%	$125M	—	$95M
Mar '22	$1.6B	$49M	0.0%	6.5%	-$41M	—	$131M
Dec '21	$1.6B	$50M	0.0%	5.0%	-$116M	—	$74M
Sep '21	$1.5B	$77M	0.0%	9.8%	$50M	—	$748M
Jun '21	$1.6B	$165M	0.0%	18.2%	$86M	—	$803M

Valuation over time

How the market has priced SEM against its own fundamentals since 2023-03 — each month-end's share price set against the most recent annual filing, so the multiple moves as price runs ahead of (or behind) earnings. Split-adjusted.

The price-to-earnings ratio has risen from 10.1× (Mar '23) to 14.0× (Jun '26).
The price-to-sales ratio has risen from 0.3× (Mar '23) to 0.4× (Jun '26).
The dividend yield has fallen from 4.0% (Mar '23) to 1.5% (Jun '26).

Price / earnings (P/E)

P/E

Price / sales (P/S)

P/S

Dividend yield (%)

Dividend yield %

Frequently asked questions

Is SEM growing its revenue and profit?

Over the past 5 years, Select Medical Holdings Corp's revenue has declined 0.3% per year, and net income declined 10.8% per year. These are computed facts, not advice.

How much debt does SEM have?

As of FY2025, Select Medical Holdings Corp reported — of total debt against $27M of cash; operating income covered interest expense 2.9×.

What is SEM's profit margin?

In FY2025, gross margin was —, operating margin 6.2%, and net margin 2.7%.

What is SEM's P/E ratio?

As of Jun '26, Select Medical Holdings Corp traded at a price-to-earnings ratio of about 14.0× (market cap ÷ latest annual net income). The valuation charts above show how its P/E, P/S and dividend yield have moved with the share price. These are computed facts, not advice.

Where does this data come from?

All figures are extracted from the company’s SEC EDGAR/XBRL filings — 10-K annual reports and 10-Q quarterly reports (use the Annual / Quarterly toggle). Quarterly figures are derived from the as-filed statements (year-to-date amounts are differenced into discrete quarters). Growth rates and ratios are computed by tradmap; nothing here is investment advice.

Source: SEC EDGAR / XBRL (10-K + 10-Q filings) · prices EOD (Databento), corporate-action-adjusted · growth rates, valuation multiples & ratios computed by tradmap. Valuation uses each month-end price against the latest annual filing. Informational only — not investment advice.